Stock ScreenerStock IdeasHigh Risk, High RewardHigh Risk, High Reward StocksSpeculative companies with the highest upside potential according to WallStreet analysts. Proceed with extreme caution!
Stock ScreenerStock IdeasHigh Risk, High Reward
Consensus: Strong Buy + 1 more
Analysts: >= 2
Upside/Downside: >= 500%
| Ticker | Company | Market Cap | Price | Price Target | Upside/Downside | Top Analysts Upside/Downside | Consensus | Top Analysts Consensus | Analysts | Top Analysts | Fore. Revenue Growth | Fore. Earnings Growth | Forecast ROE | Forecast ROA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FBLG | FIBROBIOLOGICS INC | $18.93M | $0.45 | $13.00 | 2,776.11% | Strong Buy | 2 | N/A | N/A | -5,552.75% | -343.38% | |||
| KALA | KALA BIO INC | $9.23M | $1.43 | $32.67 | 2,184.41% | Buy | 3 | N/A | N/A | -893.03% | -105.64% | |||
| GOVX | GEOVAX LABS INC | $14.07M | $0.56 | $8.50 | 1,431.53% | Strong Buy | 2 | N/A | N/A | 4,539.42% | 2,393.57% | |||
| MRSN | MERSANA THERAPEUTICS INC | $46.11M | $9.24 | $140.00 | 1,415.15% | Strong Buy | 2 | 12.06% | N/A | N/A | -12.89% | |||
| FGEN | FIBROGEN INC | $42.66M | $10.55 | $146.50 | 1,288.63% | Buy | 2 | N/A | N/A | N/A | -19.10% | |||
| CERO | CERO THERAPEUTICS HOLDINGS INC | $3.99M | $3.31 | $45.00 | 1,259.52% | Strong Buy | 2 | N/A | N/A | N/A | N/A | |||
| ATYR | ATYR PHARMA INC | $94.34M | $1.06 | $13.63 | 1,185.38% | Buy | 4 | N/A | N/A | 35.58% | 27.46% | |||
| UNCY | UNICYCIVE THERAPEUTICS INC | $78.42M | $4.44 | $57.00 | 1,183.78% | Strong Buy | 3 | N/A | N/A | 796.95% | 436.51% | |||
| ACXP | ACURX PHARMACEUTICALS INC | $11.85M | $7.48 | $95.50 | 1,176.74% | Buy | 2 | N/A | N/A | -1,395.33% | -808.10% | |||
| NRXP | NRX PHARMACEUTICALS INC | $62.47M | $3.17 | $40.00 | 1,161.83% | Strong Buy | 3 | N/A | N/A | -276.64% | 2,036.49% | |||
| SGMO | SANGAMO THERAPEUTICS INC | $202.75M | $0.67 | $8.33 | 1,140.03% | Strong Buy | 3 | 8.11% | N/A | 92.35% | 18.56% | |||
| GRI | GRI BIO INC | $4.68M | $1.86 | $22.50 | 1,109.68% | Buy | 2 | N/A | N/A | -26.50% | -15.51% | |||
| PSTV | PLUS THERAPEUTICS INC | $69.49M | $0.70 | $8.00 | 1,042.86% | Strong Buy | 4 | 41.26% | N/A | 359.89% | 105.50% | |||
| FEMY | FEMASYS INC | $16.70M | $0.61 | $7.00 | 1,041.92% | Strong Buy | 2 | 159.81% | N/A | -122.78% | -18.46% | |||
| BTAI | BIOXCEL THERAPEUTICS INC | $36.97M | $2.54 | $26.67 | 949.88% | Buy | 3 | 405.49% | N/A | N/A | N/A | |||
| LSTA | LISATA THERAPEUTICS INC | $20.38M | $2.37 | $23.50 | 891.56% | Strong Buy | 2 | 240.34% | N/A | -33.23% | -29.08% | |||
| MDCX | MEDICUS PHARMA LTD | $44.18M | $2.48 | $23.50 | 847.58% | Strong Buy | 2 | N/A | N/A | -82.26% | -22.39% | |||
| MTVA | METAVIA INC | $23.67M | $0.98 | $9.00 | 820.25% | Strong Buy | 3 | N/A | N/A | -279.09% | -145.51% | |||
| CING | CINGULATE INC | $22.25M | $4.11 | $36.50 | 788.08% | Strong Buy | 2 | N/A | N/A | N/A | N/A | |||
| ENLV | ENLIVEX THERAPEUTICS LTD | $27.44M | $1.15 | $10.00 | 769.57% | Strong Buy | 2 | N/A | N/A | -71.37% | -60.18% | |||
| SKYE | SKYE BIOSCIENCE INC | $53.61M | $1.73 | $15.00 | 767.05% | Buy | 3 | N/A | N/A | -140.13% | -117.33% | |||
| CRDL | CARDIOL THERAPEUTICS INC | $85.98M | $1.04 | $9.00 | 765.38% | Buy | 2 | N/A | N/A | 158.27% | 93.74% | |||
| BOLT | BOLT BIOTHERAPEUTICS INC | $11.13M | $5.80 | $50.00 | 762.07% | Buy | 2 | N/A | N/A | N/A | N/A | |||
| SLN | SILENCE THERAPEUTICS PLC | $235.93M | $5.00 | $42.60 | 752.00% | Buy | 5 | 8.38% | N/A | N/A | -94.33% | |||
| MBRX | MOLECULIN BIOTECH INC | $14.36M | $0.47 | $4.00 | 743.88% | Buy | 2 | N/A | N/A | N/A | -67.32% | |||
| JSPR | JASPER THERAPEUTICS INC | $39.01M | $2.40 | $20.14 | 739.29% | Buy | 7 | N/A | N/A | -387.30% | -195.88% | |||
| NOTE | FISCALNOTE HOLDINGS INC | $66.87M | $4.66 | $37.50 | 704.72% | Strong Buy | 2 | -11.65% | N/A | -33.81% | -11.15% | |||
| ANVS | ANNOVIS BIO INC | $33.13M | $1.70 | $13.50 | 694.12% | Strong Buy | 2 | N/A | N/A | -160.52% | -137.15% | |||
| IMUX | IMMUNIC INC | $86.14M | $0.90 | $7.00 | 678.64% | Strong Buy | 4 | N/A | N/A | N/A | -200.84% | |||
| VNRX | VOLITIONRX LTD | $49.49M | $0.46 | $3.50 | 660.87% | Strong Buy | 3 | N/A | N/A | N/A | N/A | |||
| INTS | INTENSITY THERAPEUTICS INC | $14.35M | $0.31 | $2.25 | 637.70% | Strong Buy | 2 | N/A | N/A | -517.12% | -254.19% | |||
| MYO | MYOMO INC | $40.83M | $1.08 | $7.83 | 625.28% | Buy | 3 | N/A | N/A | N/A | N/A | |||
| PMN | PROMIS NEUROSCIENCES INC | $25.39M | $0.49 | $3.50 | 614.29% | Strong Buy | 2 | N/A | N/A | -2,302.04% | 92.61% | |||
| EKSO | EKSO BIONICS HOLDINGS INC | $12.90M | $4.94 | $34.75 | 603.44% | Strong Buy | 2 | 17.65% | N/A | -2.15% | -1.01% | |||
| PASG | PASSAGE BIO INC | $26.93M | $8.47 | $59.25 | 599.45% | Strong Buy | 4 | N/A | N/A | -8.89% | -4.29% | |||
| RNXT | RENOVORX INC | $40.68M | $1.11 | $7.50 | 575.68% | Buy | 2 | 222.30% | N/A | 92.98% | 72.52% | |||
| ALLO | ALLOGENE THERAPEUTICS INC | $272.91M | $1.23 | $8.00 | 550.41% | Strong Buy | 7 | N/A | N/A | -46.15% | -33.79% | |||
| TIL | INSTIL BIO INC | $129.82M | $19.23 | $125.00 | 550.03% | Buy | 2 | N/A | N/A | -32.66% | -18.62% | |||
| PHIO | PHIO PHARMACEUTICALS CORP | $12.61M | $2.20 | $14.00 | 535.79% | Buy | 2 | N/A | N/A | -26.10% | -23.31% | |||
| HUMA | HUMACYTE INC | $247.06M | $1.56 | $9.80 | 528.21% | Strong Buy | 5 | 355.34% | N/A | 39.08% | 1.14% | |||
| BMEA | BIOMEA FUSION INC | $99.97M | $1.68 | $10.50 | 525.00% | Strong Buy | 6 | N/A | N/A | -363.41% | -136.65% | |||
| ACET | ADICET BIO INC | $79.98M | $0.97 | $6.00 | 520.48% | Strong Buy | 2 | N/A | N/A | -47.64% | -40.22% | |||
| CTSO | CYTOSORBENTS CORP | $57.35M | $0.92 | $5.50 | 500.44% | Buy | 2 | 14.28% | N/A | -43.05% | -12.33% |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.